(S)-1-((3'-methyl-2',5'-dioxo-6,8-dihydrospiro[cyclopenta[g]quinoline-7,4'-imidazolidine]-2-yl)methyl)-1H-imidazo[1,5,4-de]quinoxaline-2,5(4H,6H)-dione

ID: ALA1090848

PubChem CID: 46885135

Max Phase: Preclinical

Molecular Formula: C25H20N6O4

Molecular Weight: 468.47

Molecule Type: Small molecule

Names and Identifiers

Canonical SMILES:  CN1C(=O)NC(=O)[C@@]12Cc1cc3ccc(Cn4c(=O)n5c6c(cccc64)NC(=O)C5)nc3cc1C2

Standard InChI:  InChI=1S/C25H20N6O4/c1-29-23(34)28-22(33)25(29)9-14-7-13-5-6-16(26-18(13)8-15(14)10-25)11-30-19-4-2-3-17-21(19)31(24(30)35)12-20(32)27-17/h2-8H,9-12H2,1H3,(H,27,32)(H,28,33,34)/t25-/m0/s1

Standard InChI Key:  NIDRSUIUJBMPLL-VWLOTQADSA-N

Molfile:  

     RDKit          2D

 35 41  0  0  0  0  0  0  0  0999 V2000
   18.7199   -7.5214    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.2425   -8.1599    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   20.0113   -7.8602    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.9639   -7.0365    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   19.1658   -6.8272    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.7042   -8.2473    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.7789   -6.5987    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.4777   -7.0454    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.4362   -7.8665    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.2042   -8.1598    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.2715   -6.8313    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.8661   -6.0583    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   20.7056   -8.3061    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   19.0331   -8.9580    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.0130   -7.7988    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.0449   -6.9823    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.5947   -7.8670    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.1256   -8.4891    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.1244   -9.3165    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.8394   -9.7295    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.5560   -9.3161    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.5542   -8.4908    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.1693   -7.9375    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   12.8340   -7.1806    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.2471   -6.4663    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   13.9041   -8.3129    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.3229   -8.2440    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   15.2361   -6.6022    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.5491   -7.0496    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.8376   -8.0762    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.0143   -7.2703    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   11.4081   -6.7175    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.6217   -6.9651    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.4451   -7.7708    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   10.0129   -6.4082    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  7 16  2  0
  8  9  2  0
  2  3  1  0
 18 19  2  0
  3  4  1  0
 19 20  1  0
  4  5  1  0
 20 21  2  0
 21 22  1  0
 30 18  1  0
 30 22  2  0
  1  5  1  1
  9 10  1  0
 10  1  1  0
 22 23  1  0
 23 24  1  0
 24 31  1  0
  1 11  1  0
 24 25  2  0
 11  8  1  0
 23 26  1  0
 26 17  1  0
  2  1  1  0
 17 27  2  0
 27 15  1  0
  5 12  2  0
 16 28  1  0
 15  6  2  0
 28 29  2  0
 29 17  1  0
 30 31  1  0
  3 13  2  0
  6  9  1  0
  2 14  1  0
 15 16  1  0
 31 32  1  0
 32 33  1  0
 33 34  1  0
 34 18  1  0
  8  7  1  0
 33 35  2  0
M  END

Alternative Forms

1. Parent:

   

   ALA1090848

   (7S)-2-[(2,10-dioxo-1,3,9-triazatricyclo[6.3.1.04,12]dodeca-4,6,8(12)-trien-3-yl)methyl]-1'-methylspiro[6,8-dihydrocyclopenta[g]quinoline-7,5'-imidazolidine]-2',4'-dione

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Small molecule

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 468.47

Molecular Weight (Monoisotopic): 468.1546

AlogP: 1.37

#Rotatable Bonds: 2

Polar Surface Area: 118.33

Molecular Species: NEUTRAL

HBA: 7

HBD: 2

#RO5 Violations: ┄

HBA (Lipinski): 10

HBD (Lipinski): 2

#RO5 Violations (Lipinski): ┄

CX Acidic pKa: 9.45

CX Basic pKa: 3.17

CX LogP: 1.28

CX LogD: 1.28

Aromatic Rings: 4

Heavy Atoms: 35

QED Weighted: 0.43

Np Likeness Score: -0.59

References

1. Stump CA, Bell IM, Bednar RA, Fay JF, Gallicchio SN, Hershey JC, Jelley R, Kreatsoulas C, Moore EL, Mosser SD, Quigley AG, Roller SA, Salvatore CA, Sharik SS, Theberge CR, Zartman CB, Kane SA, Graham SL, Selnick HG, Vacca JP, Williams TM..  (2010)  Identification of potent, highly constrained CGRP receptor antagonists.,  20  (8): [PMID:20299218] [10.1016/j.bmcl.2010.02.086]

Source

Source(1):

• Scientific Literature